Cited by 242Immune Response and InflammationInflammatory Bowel DiseaseGastrointestinal motility and disorders

Intestinal myofibroblasts in innate immune responses of the intestine

Open access
Otte, Jan-Michel, Rosenberg, Ian M, Podolsky, Daniel K·2003·Gastroenterology

Abstract

Background & aims Intestinal myofibroblasts are known to respond to inflammatory signals and may play a role in Crohn's disease-associated fibrosis. However, putative involvement by myofibroblasts in innate immune responses as part of intestinal host defense has not been characterized. We therefore analyzed expression and regulation of toll-like receptors (TLRs) in colonic human myofibroblasts (CCD-18) and primary human colonic myofibroblasts in comparison with human lung myofibroblasts (CCD-37).Methods Expression of TLRs (1-10) and NOD 1 and 2 was assessed before and after stimulation with either lipopolysaccharide (LPS) or lipoteichoic acid (LTA) by using a custom microarray, reverse-transcription polymerase chain reaction, Northern blot and Western blot analysis, and immunohistochemistry. Activation of signaling pathways, translocation of p65, and secretion of interleukin (IL)-8 were determined.Results Messenger RNAs encoding for TLR1-9, as well as NOD1 and NOD2, were amplified from cultured and primary human intestinal myofibroblasts. After stimulation with LPS or LTA, a 1.5-4.2-fold up-regulation of TLRs (2, 3, 4, 6, 7) and elements of the signaling cascade (MyD88, TIR domain-containing adapter protein [TIRAP]) was observed. CCD-18 and CCD-37 cells expressed TLR 2 and 4 protein, which were located primarily on the cell membrane. Stimulation with LTA or LPS resulted in activation of the mitogen-activated protein kinases pathway, nuclear translocation of p65, and significantly increased IL-8 secretion.Conclusions Bacterial components directly activate intestinal myofibroblasts expressing TLRs. These cells may therefore participate in innate immune responses by sensing and responding to bacterial products that have penetrated into the subepithelial compartment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0016-5085(03)00403-7

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysbiosis, defined as an altered disease-associated microbiome, increases with the severity of NASH in both rodents and humans.

    “‘Dysbiosis’, defined as an altered disease-associated microbiome, has been shown to increase with the severity of NASH in both rodents and in humans. This is paralleled and closely related to increased intestinal permeability, bacterial translocation into the portal system and activation of pro-inflammatory pathways.148”
  • The downstream kinase IRAK4 controlled pericyte myofibroblast conversion in vitro, and pharmacological inhibition of MyD88 signaling with an IRAK4 inhibitor reduced fibrosis by attenuating tissue injury in vivo.

    “The downstream kinase IRAK4 controlled pericyte myofibroblast conversion in vitro and pharmacological inhibition of MyD88 signaling with an IRAK4 inhibitor reduced fibrosis by attenuating tissue injury in vivo167”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [167]

  • In the kidney, pericytes activate a TLR2/TLR4/MyD88-dependent proinflammatory program in response to tissue injury.

    “In the kidney, pericytes, a myofibroblast precursor, activate a TLR2/TLR4/MyD88-dependent proinflammatory program in response to tissue injury167”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [167]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 63 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Otte, J.-M., Rosenberg, I. M., & Podolsky, D. K.
Affiliations
Harvard University (US)
Corresponding author
Podolsky, Daniel K
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2003-06
Volume
124
Issue
7
Pages
1866-1878
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1984107869
Cited by
242
References
63
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 7 · 2016: 6 · 2015: 17 · 2014: 12 · 2013: 11 · 2012: 16
FWCI
4.00
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK 433-51, R01 DK 60049, R01DK060049, P30DK043351)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
intestinal myofibroblasts, innate immunity, Toll-like receptors, NOD1, NOD2, lipopolysaccharide, lipoteichoic acid, MyD88, TIRAP, MAPK signaling, p65 nuclear translocation, interleukin-8, colonic myofibroblasts, lung myofibroblasts, bacterial sensing
MeSH terms
Cells, Cultured, Colon, Fibroblasts, Humans, Immunity, Innate, Intestinal Mucosa, Lipopolysaccharides, Membrane Glycoproteins, Receptors, Cell Surface, RNA, Messenger, Teichoic Acids, Inflammatory Bowel Diseases, Interleukin-8, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mitogen-Activated Protein Kinases, Toll-Like Receptors, Toll-Like Receptor 1, Toll-Like Receptor 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review